Revenue YoY
+13.81%
Operating Income YoY
+22.25%
Net Income YoY
-73.80%
Net Margin Δ
-5813 bps
Net income bridge for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: −$3.09B-73.80%
Profit bridge breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $4.18B | — |
| Revenue | $764.70M | +24.8% |
| Cost of Revenue | −$233.20M | -7.6% |
| Operating Expenses | −$214.90M | -7.0% |
| Other Income / Expense | −$633.70M | -20.5% |
| Income Tax | −$48.60M | -1.6% |
| Other Items | −$2.72B | -88.1% |
| Net Income | $1.09B | — |
- Prior Net Income$4.18B
- Revenue$764.70M
- Cost of Revenue−$233.20M
- Operating Expenses−$214.90M
- Other Income / Expense−$633.70M
- Income Tax−$48.60M
- Other Items−$2.72B
- Net Income$1.09B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement